Bolt Biotherapeutics, Inc.
BOLT Healthcare Biotechnology
In the quarter to June 2026, revenue fell 99.7%, EPS fell 2.47%, free cash flow grew 38.9% and total debt fell 14.3%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow BOLT
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(28.74) | (29.58) | (33.38) | (42.68) |
+8 more TTM periods Free account |
Depreciation & Amortization |
0.51 | 0.59 | 0.62 | 0.65 | |
Non Cash Items (Other) |
5.58 | 5.16 | 5.02 | 5.91 | |
Change in payables and accrued liability |
(3.28) | (4.32) | (5.43) | (7.93) | |
Other operating activities |
(5.52) | (6.36) | (6.68) | (3.07) | |
Operating Cash Flow |
(31.45) | (34.51) | (39.85) | (47.12) | |
Capital expenditures |
0.63 | (0.04) | 0.89 | 0.89 | |
Short Term Investments Change (Net) |
34.02 | 37.72 | 43.41 | 54.57 | |
Investing cash flow |
34.65 | 37.67 | 44.30 | 55.46 | |
Equity Repurchase (Common, Net) |
0.03 | 0.03 | 0.05 | 0.04 | |
Financing cash flow |
0.03 | 0.03 | 0.05 | 0.04 | |
Change in Cash |
3.23 | 3.19 | 4.47 | 8.38 | |
Beginning Cash |
13.44 | 13.44 | 8.97 | 8.97 | |
Ending Cash |
16.67 | 16.63 | 13.44 | 17.35 | |
Stock Based Compensation |
2.55 | 2.62 | 2.78 | 2.92 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(3.28) | (4.32) | (5.43) | (7.93) | |
Investments Change (Net) |
34.02 | 37.72 | 43.41 | 54.57 | |
Issuance/Purchase of Shares |
0.03 | 0.03 | 0.05 | 0.04 |